Wenliang Chen | Clinical medicine | Best Researcher Award

Published on by Academic Awards

Assoc. Prof. Dr. Wenliang Chen | Clinical medicine | Best Researcher Award

Assoc. Prof. Dr. Wenliang Chen, Shanxi Medical University, China

Dr. Wenliang Chen completed his Bachelor’s degree in Clinical Medicine at Shanxi Medical University in 1996. He further pursued a Master’s degree in General Surgery at the same institution, graduating in 2002. To deepen his expertise, he obtained a Doctor of Medicine in General Surgery from the prestigious Chinese PLA General Hospital in 2023. His academic journey reflects a steadfast commitment to advancing surgical knowledge and practices, supported by specialized training in Surgical ICU and Gastrointestinal Surgery at leading hospitals in China and the USA.

Publication Profile

Orcid

Education 🎓

Dr. Wenliang Chen completed his Bachelor’s degree in Clinical Medicine at Shanxi Medical University in 1996. He further pursued a Master’s degree in General Surgery at the same institution, graduating in 2002. To deepen his expertise, he obtained a Doctor of Medicine in General Surgery from the prestigious Chinese PLA General Hospital in 2023. His academic journey reflects a steadfast commitment to advancing surgical knowledge and practices, supported by specialized training in Surgical ICU and Gastrointestinal Surgery at leading hospitals in China and the USA.

Experience 💼

Dr. Chen’s career spans more than 20 years, beginning as a General Surgeon at the Second Hospital of Shanxi Medical University. His experience includes advanced surgical training at Beijing Chaoyang Hospital and Peking University People’s Hospital. Additionally, he gained international insights as a Visiting Scholar at Duke University Medical Center and The Ohio State University. Since 2015, he has been a prominent figure in gastrointestinal and minimally invasive surgeries. His dedication to patient care and academic mentorship has greatly contributed to the institution’s medical excellence.

Awards and Honors 🏆

Assoc. Prof. Dr. Wenliang Chen has earned numerous accolades for his contributions to the field of surgery. His pioneering efforts in obesity and diabetes surgery in Shanxi Province and his successful laparoscopic Nissen fundoplication for gastroesophageal reflux disease have established him as a surgical innovator. Furthermore, his active roles in national and provincial medical committees, including the Colorectal Cancer Committee and the Gastrointestinal Surgery Committee, exemplify his leadership and dedication to medical advancement.

Research Focus 🔎

Dr. Chen’s research primarily focuses on the diagnosis and surgical treatment of gastrointestinal diseases. He has led significant studies, notably as Principal Investigator on the regulatory mechanism of LncRNA PVT1 in gastric cancer proliferation and invasion. His interest in minimally invasive surgeries has led to advancements in laparoscopic techniques, benefiting patient recovery and surgical outcomes. His dedication to translational research has strengthened the clinical application of innovative treatments, contributing to the advancement of gastrointestinal oncology and metabolic disease management.

Publication Top Notes

📄 Innovative Approaches to Managing Postoperative Complications in Laparoscopic Sleeve Gastrectomy: A Scoping Review (2024) | 🏛 Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A | 🔗 DOI: 10.1089/lap.2024.0227

📄 Oxidative stress-related patterns determination for establishment of prognostic models, and characteristics of tumor microenvironment infiltration (2022) | 🏛 Frontiers in Surgery | 🔗 DOI: 10.3389/fsurg.2022.1013794

📄 Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer (2022) | 🏛 Frontiers in Immunology | 🔗 DOI: 10.3389/fimmu.2022.962056

📄 Efficacy and safety of over-the-scope clips for colorectal leaks and fistulas: a pooled analysis (2022) | 🏛 Minimally Invasive Therapy & Allied Technologies | 🔗 DOI: 10.1080/13645706.2021.2010218

📄 LncRNA SNHG6 inhibits autophagy of gastric carcinoma cells via PI3K/AKT/mTOR signaling pathway (2022) | 🏛 American Journal of Translational Research | 🔗 PMID: 35702105

📄 The Role of lncRNA PVT1 and hsa-miR-30a-3p in the Development of Gastric Cancer (2022) | 🏛 Annals of Clinical and Laboratory Science | 🔗 PMID: 35414508

📄 Laparoscopy for Hepatolithiasis: Biliary Duct Exploration with Primary Closure Versus T-Tube Drainage (2020) | 🏛 Journal of Laparoendoscopic & Advanced Surgical Techniques | 🔗 DOI: 10.1089/lap.2020.0081

📄 A Comparison of the Relative Safety and Efficacy of Laparoscopic Choledochotomy with Primary Closure and Endoscopic Treatment for Bile Duct Stones in Patients with Cholelithiasis (2020) | 🏛 Journal of Laparoendoscopic & Advanced Surgical Techniques | 🔗 DOI: 10.1089/lap.2019.0775

 

Bikash khadka | Medicine and Dentistry | Best Researcher Award

Published on by Academic Awards

Dr. Bikash khadka | Medicine and Dentistry | Best Researcher Award

Dr. Bikash khadka , Nepal Mediciti , Nepal

Dr. Bikash Khadka is a dedicated anesthesiologist from Lalitpur, Kathmandu, Nepal, with extensive experience in critical care and perioperative medicine. He earned his MD in Anesthesiology from Lumbini Medical College, affiliated with Kathmandu University, in 2018, after completing his MBBS at Kathmandu University School of Medical Sciences in 2012. Dr. Bikash Khadka currently serves as a Junior Consultant Anesthesiologist at Nepal Mediciti Hospital, where he manages a 32-bed mixed ICU and conducts anesthesia for various surgeries. Passionate about medical education, he has also served as a Lecturer at Lumbini Medical College. His research focuses on anesthesia techniques, critical care, and perioperative safety, with numerous published articles in peer-reviewed journals. He is proficient in advanced airway management, regional blocks, and critical patient care. Dr. Bikash  Khadka actively participates in medical workshops and conferences to stay updated in his field.

Publication Profile

Scopus

Work Experience

Dr. Bikash Khadka has been a Junior Consultant Anesthesiologist at Nepal Mediciti Hospital since August 2019, where he manages a 32-bed mixed ICU and provides anesthesia for diverse surgeries. From November 2018 to August 2019, he worked as a Lecturer at Lumbini Medical College, teaching anesthesiology to medical students. As a Resident Doctor (2015-2018) at the same institution, he performed pre-anesthetic assessments, anesthesia conduction, ICU management, and supervised junior residents. His responsibilities included emergency surgeries, obstetric analgesia, and critical care. From September 2013 to March 2014, he was a Medical Officer at Alka Hospital, providing emergency care. His experience spans specialized anesthesia services, resuscitation, and managing patients across various surgical and ICU settings.

Education and Training

Dr. Bikash Khadka earned his MD in Anesthesiology from Lumbini Medical College, affiliated with Kathmandu University, from 2015 to 2018. Prior to that, he completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at Kathmandu University School of Medical Sciences between 2008 and 2012. During his medical education, he acquired extensive theoretical knowledge and hands-on experience, laying the foundation for his career in anesthesiology and critical care. His education focused on pre-anesthetic assessment, anesthesia conduction, ICU management, and patient care during complex surgical procedures. Dr. Bikash Khadka also completed significant training, including ACLS, BLS, airway management, and acute care ultrasound workshops, strengthening his proficiency in both clinical and emergency care. His commitment to continual learning is reflected in his active participation in national conferences and specialized courses.

Awards and Training

Dr. Bikash Khadka has attended various prestigious conferences and workshops, including the 17th National Conference of the Society of Anesthesiologists of Nepal (SANCON) in 2016. He participated in specialized workshops like the Difficult Airway Workshop and Acute Care Ultrasound Workshop. He holds certifications in Advanced Cardiovascular Life Support (ACLS) and Basic Life Support (BLS), showcasing his dedication to critical care excellence. His commitment to academic excellence is evident through his lecturer role and involvement in training junior residents. Dr. Bikash Khadka’s clinical expertise and research contributions have established him as a respected professional in anesthesiology and critical care in Nepal.

Research Focus

Dr. Bikash Khadka’s research focuses on anesthesiology, critical care, and perioperative management. His interests include optimizing patient outcomes in ICU settings, managing complex airway cases, and preventing anesthesia-related complications. He has contributed to research on rare medical conditions, such as Boerhaave syndrome and post-COVID-19 vaccine complications. Dr. Bikash khadka is also interested in comparative studies on pharmacological agents to improve surgical outcomes, such as using dexmedetomidine and dexamethasone for postoperative nausea prevention. His work often explores innovative approaches to regional anesthesia, patient safety, and critical care protocols. His systematic reviews and case reports provide valuable insights into anesthesia practice and patient management.

Publication Top Notes 📚

Role of pre-operative counseling with NSQIP surgical risk calculator in the surgical patients

Authors: Khadka, B., Sharma, A., Bhattarai, P.R., Rayamajhi, B., Adhikari, H.

Journal: Surgery Open Science

Year: 2024

Volume: 18, pp. 11–16

Citations: 0

Pyopericardium progressing to cardiac tamponade in a patient with dengue fever

Authors: Khadka, B., Khanal, K., Regmi, A., KC, S., Nepal, R.

Journal: IDCases

Year: 2024

Volume: 36, Article e01996

Citations: 0

Removing knotted or stuck epidural catheters: a systematic review of case reports

Authors: Khadka, B., Sharma, A., Regmi, A., Ghimire, A., Bhattarai, P.R.

Journal: Anesthesia and Pain Medicine

Year: 2023

Volume: 18(3), pp. 315–324

Citations: 1

A rare case of Boerhaave syndrome with cervico-thoracic esophageal junction rupture causing bilateral empyema; case report from Nepal

Authors: Khadka, B., Khanal, K., Dahal, P., Adhikari, H.

Journal: International Journal of Surgery Case Reports

Year: 2023

Volume: 105, Article 108018

Citations: 2

Post COVID-19 vaccine Guillain-Barré syndrome

Authors: Khadka, B., Khanal, K.

Journal: Journal of Nepal Health Research Council

Year: 2022

Volume: 19(4), pp. 852–854

Citations:

 

 

 

 

Haojie Shan | Medicine and Dentistry | Best Researcher Award

Published on by Academic Awards

Dr. Haojie Shan | Medicine and Dentistry | Best Researcher Award

Dr. Haojie Shan, Department of orthopedic surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China

Dr. Haojie Shan is a dedicated Resident Surgeon at the Department of Orthopaedic Surgery, Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University. He holds a Ph.D. and M.D. in Orthopaedic Surgery from the same university and a B.S. in Clinical Medicine from Henan University. His research interests include osteonecrosis of the femoral head, bone immunity, and biomedical materials. Dr. Shan has authored numerous publications and holds several patents in surgical innovation. He has received prestigious awards, including a Gold Award in the International Innovation Competition for College Students in China. 📚🏆🦴

 

Publication Profile

Scopus

Education

Dr. Haojie Shan completed his academic journey in the field of orthopaedic surgery with impressive credentials. He earned his Ph.D. in Surgery (Orthopaedics) from Shanghai Jiao Tong University in June 2023, following the completion of his M.D. in the same specialty in June 2020. Prior to that, he obtained his B.S. in Clinical Medicine from Henan University in June 2017. Dr. Shan’s extensive education reflects his dedication to advancing medical knowledge and surgical techniques in orthopaedics. 🦴🎓🏥

 

Research Interests

Dr. Haojie Shan is deeply engaged in innovative research within the field of orthopaedics, focusing on several critical areas. His primary interests include osteonecrosis of the femoral head, where he explores its underlying mechanisms and treatment strategies. He also investigates bone immunity and regeneration, aiming to enhance healing processes. Furthermore, Dr. Shan studies bone and soft tissue infections, seeking to improve diagnosis and therapeutic approaches. His work extends to the development and application of biomedical materials, which play a crucial role in orthopaedic surgery. His research contributes significantly to advancing patient care and treatment outcomes. 🦴🔬💉✨

 

Honors and Awards

Dr. Haojie Shan has garnered numerous accolades for his exceptional contributions to the field of orthopaedics and medical innovation. In 2024, he received the Gold Award in the Shanghai Division and a National Silver Award at the International Innovation Competition for College Students in China. His achievements include winning the First Prize at the 12th International Conference on Rehabilitation Medicine and Engineering Innovation Competition in 2023. Additionally, he secured the Second Prize for “Outstanding Youth” Papers at the same conference. Dr. Shan also earned a Third Prize in the China Medical Device Innovation and Entrepreneurship Competition and received recognition at various other esteemed events. 🥇🏆🎖️✨

 

Conclusion

Dr. Haojie Shan’s combination of education, research expertise, innovative contributions, and recognition in the orthopaedic surgery domain make him a highly suitable candidate for the Research for Best Researcher Award. His work not only demonstrates academic excellence but also a profound commitment to advancing medical science for improved patient outcomes.

 

Publication Top Notes  

  • A chitosan/gelatin/aldehyde hyaluronic acid hydrogel coating releasing calcium ions and vancomycin in pH response to prevent the formation of bacterial biofilm – Li, Y., Sung Min, H., Chen, C., … Lu, L., Yu, X. (2025) – 0 citations 📜
  • Copper-infused zinc porphyrin supramolecular polymersomes for triple synergistic combat against wound bacterial biofilm infections – Yang, L., Du, Y., Yin, F., … Zhou, Y., Yu, X. (2024) – 0 citations 💉
  • An Intelligent Hydrogel Platform with Triple-Triggered On-Demand Release for Accelerating Diabetic Wound Healing – Zhang, X., Li, Y., Zhao, Z., … Ren, R., Du, C., Yu, X. (2024) – 0 citations 🩹
  • Scd-1 deficiency promotes the differentiation of CD8+ T effector – Lin, Y., Li, X., Shan, H., … Liu, F., Yu, X. (2024) – 1 citation 💉
  • Effects of astragaloside IV on glucocorticoid-induced avascular necrosis of the femoral head via regulating Akt-related pathways – Shan, H., Lin, Y., Yin, F., … Zhou, Z., Yu, X. (2023) – 4 citations ⚖️
  • Dimethyl Oxalylglycine Activates Tendon-Derived Stem Cells to Promote Regeneration of Achilles Tendon Rupture in Rats via HIF-1α – Wang, Y., Li, M., Lin, Y., … Shan, H., Wu, T., Yu, X. (2023) – 2 citations 🦵
  • The Ubiquitination of RIPK2 is Mediated by Peli3 and Negatively Regulates the Onset of Infectious Osteomyelitis – Le, L., Shan, H., Lin, Y., … Shi, Z., Xu, Y., Yu, X. (2023) – 0 citations 🦠
  • Ubiquitin-Specific Peptidase 8 Is Critical for the Onset of Infectious Osteomyelitis by Targeting RIPK2 Ubiquitination – Chen, Y., Wan, Y., Shan, H., … Jiang, C., Shi, Z., Yu, X. (2023) – 0 citations 🔬
  • Staphylococcus aureus Infection Initiates Hypoxia-Mediated Transforming Growth Factor-b1 Upregulation to Trigger Osteomyelitis – Zhang, W., Lin, Y., Zong, Y., … Zhou, Z., Yu, X. (2022) – 9 citations 🦠
  • Ginsenoside Rg1 enhances the healing of injured tendon in Achilles tendinitis through the activation of IGF1R signaling mediated by oestrogen receptor – Wu, T., Qi, W., Shan, H., … Lu, Y., Wang, F., Yu, X. (2022) – 6 citations 🌱

 

 

 

Fei Yu | Medicine and Dentistry | Best Researcher Award

Published on by Academic Awards

Fei Yu | Medicine and Dentistry | Best Researcher Award

Prof Fei Yu, Shanghai tenth people’s hospital, China

Prof. Fei Yu, a distinguished expert in Nuclear Medicine, holds a rich educational background with degrees from Soochow University and Fudan University. With a graduation date of June 2012 from Soochow University School of Medicine, he has dedicated himself to advancing the field of Nuclear Medicine through significant contributions and research.

Publication profile

Scopus

Education

Prof. Fei Yu graduated in June 2012 from Soochow University, where he completed his medical education. He previously attended Fudan University from September 1996 to July 2001, earning his degree from the School of Public Health and Community Medicine. Furthering his studies, Prof. Yu obtained his degree from Tongji University’s School of Medicine between March 2005 and March 2008. With a strong foundation in public health and medicine, he has made significant contributions to his field. 🌍📚🏥

Honors and Awards

Prof. Fei Yu is a distinguished researcher recognized for his significant contributions to nuclear medicine. He was awarded the Star of Hope Award by the Chinese Society of Nuclear Medicine in September 2018. His project on targeted therapy for non-small cell lung cancer, supported by the Shanghai Talent Development Fund in September 2017, highlights his innovative approach in the field. He also received the Shanghai Science and Technology Award in November 2010 for developing a 99mTc labeled somatostatin receptor imaging kit for lung cancer diagnosis. Additionally, he was honored with the Huaxia Medical Science and Technology Award and the Hospital Technology Innovation Award for his research on medical ethics and intelligent clinical pathways. 🌟🔬🏆

Research Achievements

Dr. Yang and colleagues have made significant strides in cancer therapy and cardiology. Their 2024 study in Theranostics explores how damaged mitochondrial transfer impacts the bystander effect induced by alpha-particle radiation (🎗️). Another study published in Small reveals that alpha-emitter Radium-223 triggers STING-dependent pyroptosis, enhancing antitumor immunity (💉). Additionally, they developed alpha radionuclide-chelated radioimmunotherapy promoters to advance local radiotherapy strategies, published in Biomaterials Research (📚). In cardiology, their nomogram for predicting major adverse cardiac events in patients with ischemia, featured in Frontiers in Cardiovascular Medicine, is a pivotal contribution (❤️).

Research focus

Prof. Fei Yu is a prominent researcher specializing in nuclear medicine and molecular imaging. His work encompasses the development and evaluation of advanced therapeutic approaches, particularly in the context of neuroendocrine tumors and thyroid cancer. Prof. Yu’s research focuses on innovative treatments like peptide receptor radionuclide therapy and the mechanisms of antitumor immunity, including the role of STING-dependent pyroptosis induced by alpha-emitter Radium-223. His contributions significantly enhance understanding of cancer therapies and their implications for patient prognosis. 🔬💉📈

Memberships and Leadership

Prof. Yu is an active member of several professional societies, holding key positions such as Vice Chairman of the Continuing Education Committee of Nuclear Medicine under the Chinese Nuclear Society. His involvement in these organizations reflects his dedication to the growth and education within the field, emphasizing the importance of collaboration and knowledge sharing.

Funding and Research Projects

Prof. Yu leads multiple funded projects, including the National Natural Science Foundation project on interstitial radiotherapy combined with immunotherapy for non-small cell lung cancer. His work is characterized by a strong focus on innovative therapies that integrate radiological techniques with emerging treatment modalities.

Publication top notes

Triglyceride-glucose index is associated with myocardial ischemia and poor prognosis in patients with ischemia and no obstructive coronary artery disease

The D-SPECT SH reconstruction protocol: improved quantification of small left ventricle volumes

The Effect of Radioiodine Therapy on the Prognosis of Differentiated Thyroid Cancer with Lung Metastases

Extended peptide receptor radionuclide therapy: evaluating nephrotoxicity and therapeutic effectiveness in neuroendocrine tumor patients receiving more than four treatment cycles

Alpha-Emitter Radium-223 Induces STING-Dependent Pyroptosis to Trigger Robust Antitumor Immunity

Conclusion

Prof. Fei Yu exemplifies excellence in nuclear medicine, with a career marked by substantial research contributions, leadership roles, and a commitment to advancing medical science. His innovative approaches to cancer therapy and active involvement in professional societies make him an outstanding candidate for the Best Researcher Award. Prof. Yu’s dedication to improving patient outcomes through research and education sets a high standard for future professionals in the field.

Miguel Virseda-Chamorro | Medicine and Dentistry | Best Researcher Award

Published on by Academic Awards

Dr. Miguel Virseda-Chamorro | Medicine and Dentistry | Best Researcher Award

Dr. Miguel Virseda-Chamorro, Hospital Nacional de parapléjicos, Spain

Dr. Miguel Virseda-Chamorro is a distinguished urologist with extensive expertise in urodynamics and pelvic floor disorders. He earned his MD from the University of Valencia in 1981 and specialized in Urology at Gómez Ulla Hospital in 1990. He holds a PhD, awarded cum laude in 1992, and completed further education in Health Sciences Statistics. Dr. Virseda is a Fellow of the European Board of Urology and has contributed to major scientific journals. Recognized with several prestigious awards, his research has impacted functional urology and neurogenic bladder treatment. He is fluent in multiple languages and an active member of several urological societies. 🏥🧬📊

Publication Profile

Scopus

Orcid

Academic Formation and Specializations

Dr. Virseda-Chamorro has an impressive academic trajectory, beginning with a Licenciatura in Medicine and Surgery from the University of Valencia (1981) and multiple specialized courses in Urology and Medical Aeronautics. He has also pursued advanced degrees, including a Master in Health Sciences Design and Statistics (2001), which supports his clinical research. His PhD in Urology, awarded with distinction, further underscores his expertise in the field.

Awards and Distinctions

His outstanding contributions have been recognized through several prestigious awards, such as the Best Doctoral Thesis Awards (1992, 1995), and multiple honors from the Spanish Urology Association for his groundbreaking research. These recognitions validate his impact on the field of urology, particularly in areas like urodynamic models and pelvic prolapse treatment.

Teaching and Clinical Trials

Dr. Virseda-Chamorro has also made significant contributions to medical education, leading various courses on pelvic floor treatment and urodynamic pediatric pathologies. His participation in numerous clinical trials, such as evaluating the efficacy of beta-3 agonists for overactive bladder, shows his ongoing commitment to advancing medical knowledge and patient care.

Conclusion

Dr. Miguel Virseda-Chamorro’s rich academic background, clinical expertise, significant research contributions, and numerous honors make him an ideal candidate for the Best Researcher Award. His dedication to both clinical practice and advancing scientific understanding in urology highlights his qualification for this prestigious recognition.

 

Publication Top Notes

  • Can We Differentiate Between Organic and Functional Bladder Outlet Obstruction in Males With Parkinson’s Disease? (2024)  🧠📅
  • Factors Influencing Postoperative Overactive Bladder after Adjustable Trans-Obturator Male System Implantation for Male Stress Incontinence following Prostatectomy (2023) – 1 citation 💉📅
  • Update on Adjustable Trans-Obturator Male System (ATOMS) for Male Incontinence after Prostate Cancer Surgery (2023) – 4 citations 🦠📅
  • ATOMS in Patients with Post-Prostatectomy Incontinence and Previously Treated Urethral Stricture or Bladder Neck Contracture (2022) – 6 citations 🚻📅
  • Functional Changes during the Voiding Phase in Men with Non-Neurogenic Detrusor Underactivity Undergoing Bladder Catheterization (2022)  🧬📅
  • Compression or Obstruction: Analysis of the Function of ATOMS Based on Pre- and Postoperative Urodynamic Data (2022) – 4 citations 🛠️📅
  • Urodynamics of Urinary Retention in Guillain-Barré Syndrome Post-Infection by SARS-CoV-2 (2022) – 1 citation 🌐📅
  • Influence of ATOMS Implant on the Voiding Phase of Patients with Post-Prostatectomy Urinary Incontinence (2022) – 3 citations 🚽📅
  • Prevalence and Risk Factors for Lower Urinary Tract Symptoms after Robotic Sacrocolpopexy (2021) – 🤖📅
  • Long-term Outcome of ATOMS for Stress Urinary Incontinence in the Iberian Multicentre Study (2020) – 17 citations 📊📅

 

 

 

 

Hong De Sa | Medicine and Dentistry | Women Researcher Award

Published on by Academic Awards

Hong De Sa | Medicine and Dentistry | Women Researcher Award

Dr Hong De Sa, OHSU, United States

Based on Dr. Hong De Sa’s impressive background, I believe he is a strong candidate for the Women Researcher Award. Here are key points that highlight his qualifications:

Publication profile

Scopus

Education and Training

Dr. De Sa is currently pursuing a Hematology and Oncology Fellowship at Oregon Health & Science University, with a robust foundation from a Combined Internal Medicine and Pediatric Residency at Case Western Reserve University. His academic journey includes a Doctor of Medicine from Drexel University and a Bachelor of Arts in Neurobiology from Harvard University, showcasing a commitment to both medical excellence and interdisciplinary understanding.

Leadership and Experience

As Chief Fellow for the 2024-2025 academic year, Dr. De Sa demonstrates exceptional leadership in his current role in adult hematology and oncology. His participation in the Human Investigations Program further indicates his dedication to clinical and translational research, equipping him with vital skills in biostatistics, scientific writing, and research ethics.

Research Contributions

Dr. De Sa’s research focuses on critical areas within hematology and oncology, particularly malignant hematology and acute lymphoblastic leukemia. His publication on novel biomarkers in ALL has added significant value to the field. Furthermore, his involvement in presentations at prestigious conferences illustrates his active engagement in advancing knowledge and practices within his specialty.

Awards and Recognition

Dr. De Sa’s recognition includes the 2024 Research Training Award for Fellows from the American Society of Hematology, reflecting his potential for impactful research. His previous honors, such as the Byron R. Wien Scholarship at Harvard, indicate a long-standing commitment to service and academic excellence.

Community Engagement and Service

His service-oriented mindset is exemplified by awards recognizing his contributions to health outreach and public service initiatives during his educational journey, underscoring his dedication to improving community health outcomes.

Extracurricular Achievements

Dr. De Sa’s achievements in ultramarathoning showcase his discipline and resilience, qualities that translate well into the rigorous demands of research and clinical practice.

conclusion

Dr. Hong De Sa’s extensive training, leadership roles, research contributions, recognition, and commitment to service make him an outstanding candidate for the Women Researcher Award. His multifaceted approach to medicine and research aligns perfectly with the values and standards of this prestigious recognition.

Publication top notes

Novel Biomarkers and Molecular Targets in ALL

The impact of omidubicel on immune reconstitution and infections in cord blood transplant patients

 

 

Pedro Antonio Regidor | Medicine and Dentistry | Best Innovation Award

Published on by Academic Awards

Dr. Pedro Antonio Regidor | Medicine and Dentistry | Best Innovation Award

Dr. Pedro Antonio Regidor, Exeltis, Germany

Dr. Pedro Antonio Regidor holds dual German and Spanish citizenship. He completed his medical studies at the University of Essen and gained extensive experience in gynecology and obstetrics across Germany and Venezuela. Notably, he served as Medical Director at Exeltis Europe and Global Projects. His qualifications include specialized certifications in radiological diagnostics and gynecological endocrinology. Dr. Regidor is recognized for his contributions to women’s health and medical innovation. Currently, he continues his work as a Medical Director and private practitioner in Munich, Germany. 🌍💉

Publication profile

Scopus

Professional Background

Dr. Pedro Antonio Regidor, holding both German and Spanish citizenship, has a distinguished career in the field of gynecology and obstetrics. His educational journey began at the Deutsche Schule Madrid and continued with medical studies at the University of Essen, where he completed his state exams and medical training. His professional experience spans multiple countries and prestigious institutions, including roles as a senior physician and medical director at prominent medical centers in Germany.

Innovative Contributions

Dr. Regidor has demonstrated a commitment to advancing medical practice and patient care. His roles in various high-profile positions, including Medical Director at Exeltis Europe & Global Projects, reflect his leadership in implementing innovative practices and advancing healthcare delivery. His experience with cutting-edge medical technologies and practices, including his certifications in advanced diagnostic and therapeutic techniques, underscores his contributions to medical innovation.

Awards and Recognitions

Dr. Regidor’s career is marked by several significant recognitions, including his certifications in specialized fields such as radiological diagnostics and gynecological endocrinology. His role as a Medical Director involved overseeing global projects, indicating a strong track record of managing and implementing innovative solutions across diverse healthcare settings.

Publication Top Notes

  • “The drospirenone only pill as a contraceptive option for breastfeeding women: First data on users’ acceptability and newborn development” (Gynecological Endocrinology, 2024) 📅
  • “OPEN PROSPECTIVE STUDY TO EVALUATE THE EFFICACY OF A NEW VAGINAL PESSARY CONTAINING 300MG TINIDAZOLE, 200MG TIOCONAZOLE AND 100MG LIDOCAINE” (Reproductive Endocrinology, 2024) 📅
  • “Nausea and Vomiting of Pregnancy and its Management with the Dual-Release Formulation of Doxylamine and Pyridoxine” (Geburtshilfe und Frauenheilkunde, 2023) 📅
  • “Improvement in menopausal symptoms with a nutritional product containing evening primrose oil, hop extract, saffron, tryptophan, vitamins B6, D3, K2, B12, and B9” (European Review for Medical and Pharmacological Sciences, 2023) 📅
  • “10-month retrospective study on compliance and tolerability of the drospirenone-only pill” (European Review for Medical and Pharmacological Sciences, 2023) 📅
  • “Miconazole for the treatment of vulvovaginal candidiasis. In vitro, in vivo and clinical results. Review of the literature” (Journal of Obstetrics and Gynaecology, 2023) 📅
  • “Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen” (Women’s Health, 2023) 📅
  • “The drospirenone (DRSP)-only pill: clinical implications in the daily use” (European Journal of Contraception and Reproductive Health Care, 2023) 📅
  • “Erratum: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone” (Geburtshilfe und Frauenheilkunde, 2022) 📅
  • “Evaluation of the food effect on a drospirenone only contraceptive containing 4 mg administered with and without high-fat breakfast in a randomised trial” (BMC Women’s Health, 2022) 📅


Conclusion

Dr. Pedro Antonio Regidor’s extensive experience in gynecology, his leadership in implementing innovative healthcare practices, and his significant contributions to medical advancements, he is a strong candidate for the “Research for Best Innovation Award.” His career reflects a profound impact on medical practices and innovation, aligning well with the award’s criteria.

 

 

 

 

 

 

 

 

Ilaria Giangrandi | Medicine and Dentistry | Women Researcher Award

Published on by Academic Awards

Dr. Ilaria Giangrandi | Medicine and Dentistry | Women Researcher Award

Dr. Ilaria Giangrandi, AOU CAREGGI FIRENZE, Italy

 

Based on the provided information, Dr. Ilaria Giangrandi seems to be a strong candidate for the Research for Women Researcher Award. Here’s a summary of her qualifications and contributions:

Publication profile

Professional Experience

2023: Assigned as a temporary substitute for the SODs of Clinical Nutrition at AOU Careggi. Participated in developing nutritional pathways for oncology patients in the Tuscany region and revising procedures for artificial nutrition in head and neck cancer cases.

2022: Responsible for scientific oversight of a training event on basal metabolism assessment via indirect calorimetry.

2021-2022: Member of the technical committee for ESTAR, focusing on the provision of special foods and supplements.

2020-Present: Quality and Safety Coordinator for Clinical Nutrition at AOU Careggi; Facilitator for Clinical Risk since November 2021.

Education and Training

2024: Attended multiple educational events, including courses on functional medicine, deontology, and care for migrant health.

2023: Participated in various courses related to metabolic syndrome, radioprotection, and microbiota.

2022: Engaged in training programs on specialized artificial nutrition and worker safety.

Communication Skills

  • Developed strong communication skills through courses in neurolinguistic programming and extensive clinical experience in various hospital departments.

Professional Skills

  • Demonstrated expertise in multidisciplinary team work and specialized clinical practices, including roles in vascular ecocolordoppler and upper abdomen diagnostics.

Publication Top Notes

  • Effects of a chronotype-adapted diet on weight loss, cardiometabolic health, and gut microbiota: study protocol for a randomized controlled trial
    Dinu, M., Lotti, S., Pagliai, G., … Colombini, B., Sofi, F.
    Trials, 2024, 25(1), 152
    🏷️ [No citations]
  • Licorice and liver function in patients with primary liver disease: A systematic review and meta-analysis of RCTs
    Giangrandi, I., Dinu, M., Napoletano, A., … Firenzuoli, F., Sofi, F.
    Phytotherapy Research, 2024
    🏷️ [No citations]
  • Assessment of Mediterranean diet adherence and comparison with Italian dietary guidelines: a study of over 10,000 adults from 2019 to 2022
    Lotti, S., Napoletano, A., Tristan Asensi, M., … Dinu, M., Sofi, F.
    International Journal of Food Sciences and Nutrition, 2024, 75(3), pp. 336–343
    🏷️ 2 citations
  • Quality of life and nutritional status of a group of post-operative head and neck cancer patients
    Asensi, M.T., Giangrandi, I., Sartini, L., … Colombini, B., Sofi, F.
    Nutricion Hospitalaria, 2023, 40(5), pp. 919–923
    🏷️ [No citations]
  • Adherence to the Mediterranean Diet and Ultra-Processed Foods Consumption in a Group of Italian Patients with Celiac Disease
    Tristan Asensi, M., Pagliai, G., Lotti, S., … Sofi, F., Dinu, M.
    Nutrients, 2023, 15(4), 938
    🏷️ 7 citations
  • Morning chronotype is associated with higher adherence to the Mediterranean diet in a sample of Italian adults
    Lotti, S., Pagliai, G., Asensi, M.T., … Sofi, F., Dinu, M.
    Nutrition, Metabolism and Cardiovascular Diseases, 2022, 32(9), pp. 2086–2092
    🏷️ 14 citations
  • Adherence to Mediterranean diet increased during the COVID-19 lockdown in Italy: results from the web-based Medi-Lite questionnaire
    Lotti, S., Dinu, M., Pagliai, G., … Colombini, B., Sofi, F.
    International Journal of Food Sciences and Nutrition, 2022, 73(5), pp. 650–656
    🏷️ 8 citations
  • Effects of vegetarian versus Mediterranean diet on kidney function: Findings from the CARDIVEG study
    Dinu, M., Colombini, B., Pagliai, G., … Marcucci, R., Sofi, F.
    European Journal of Clinical Investigation, 2021, 51(9), e13576
    🏷️ 7 citations
  • Adherence to Mediterranean diet measured through medi‐lite score and obesity: A retrospective study
    Dinu, M., Pagliai, G., Lotti, S., … Colombini, B., Sofi, F.
    Nutrients, 2021, 13(6), 2007
    🏷️ 8 citations
  • Effect of consumption of ancient grain bread leavened with sourdough or with baker’s yeast on cardio-metabolic risk parameters: a dietary intervention trial
    Pagliai, G., Venturi, M., Dinu, M., … Sofi, F., Granchi, L.
    International Journal of Food Sciences and Nutrition, 2021, 72(3), pp. 367–374
    🏷️ 10 citations

  
Conclusion

Dr. Giangrandi’s extensive involvement in clinical nutrition, educational contributions, and leadership in quality and safety make her a highly suitable candidate for the Research for Women Researcher Award.

Mustafa Ozdemir | Interventional Radiology | Best Researcher Award

Published on by Academic Awards

Dr. Mustafa Ozdemir | Interventional Radiology | Best Researcher Award

Dr. Mustafa Ozdemir, sakarya university faculty of medicine, Turkey

Based on Dr. Mustafa Özdemir’s extensive qualifications and achievements, he appears to be a strong candidate for the Research for Best Researcher Award. Here’s an overview highlighting his suitability:

Publication profile

Education

Dr. Mustafa Özdemir completed his medical education at Erciyes University, Faculty of Medicine, where he earned his Doctor of Medicine degree (2003-2009). He further pursued a Radiology residency at Ondokuz Mayis University, School of Medicine, culminating in 2016 with a thesis focused on endovascular treatment methods for aneurysms.

Professional Experience

Dr. Özdemir has a broad range of professional experience. From 2009-2011, he worked as a General Practitioner in various hospitals. He then completed his Radiology Residency (2011-2016) and has served as an Interventional Radiologist at Kayseri Research and Training Hospital (2016-2020) and Sakarya University Faculty of Medicine (2020-present).

Observerships

In 2015, he completed an observership at Maryland University Hospital, focusing on Interventional Neuroradiology, which reflects his commitment to staying at the forefront of his field.

Publications

  • Measuring the optic nerve sheath diameter with ultrasound in acute middle cerebral artery stroke patients – Journal of Stroke and Cerebrovascular Diseases 30 (2), 105523 (17 citations, 2021) 🧠
  • COVID-19 enfeksiyonunda toraks bilgisayarlı tomografi bulguları – Journal of Biotechnology and Strategic Health Research 4, 91-96 (15 citations, 2020) 🦠
  • Giant invasive basal skull prolactinoma with CSF rhinorrhoea and meningitis – Clinical Neurology and Neurosurgery 120, 145-146 (12 citations, 2014) 🧩
  • On the identification of thyroid nodules using semi‐supervised deep learning – International Journal for Numerical Methods in Biomedical Engineering 37 (3) (7 citations, 2021) 🤖
  • Is biopsy necessary? Role of DCE-MRI in BIRADS-3 lesions – Diagnostic and Interventional Radiology 26 (6), 552 (6 citations, 2020) 📉
  • Chemoresponsive liver hemangioma in a patient with metastatic malignant teratoma – Clinics and Research in Hepatology and Gastroenterology 39 (1), 1-2 (4 citations, 2014) 🧪
  • Demonstration of craniocervical junction abnormalities for diagnosis of atlanto-occipital assimilation using MRI – Anatomy 12 (2), 76-82 (3 citations, 2018) 🧠
  • A new predictor of bleeding based on ultrasonographic features in percutaneous liver mass biopsy – Turkish Journal of Medical Sciences 50 (8), 1970-1975 (2 citations, 2020) 🩺
  • Gallbladder ascariasis: a case report and review of the literature – Sakarya Tıp Dergisi 9 (1), 175-179 (2 citations, 2019) 🪱
  • Comparison of the complications and long-term results of heparin-coated and non-heparin-coated symmetric-tip hemodialysis catheters – The Journal of Vascular Access 11297298231202536 (1 citation, 2023) 🩸
  • Percutaneous treatment of giant hydatid cysts: a single-center experience of 58 cysts – Abdominal Radiology 48 (4), 1409-1414 (1 citation, 2023) 🦠
  • Dermatofibrosarcoma Protuberans and Adjuvant Radiotherapy: A Case Report with Uncertain Surgical Margins in The Breast – Archives of Breast Cancer 342-349 (1 citation, 2021) 🩺
  • Spontaneous epidural pneumocephalus – Journal of Craniofacial Surgery 27 (8), e748-e749 (1 citation, 2016) 💨
  • Differential Analysis of Venous Sinus Diameters: Unveiling Vascular Alterations in Patients with Multiple Sclerosis – Diagnostics 14 (16), 1760 (2024) 🧠
  • Relationship between carotid artery stenosis percentage and complications in patients treated with carotid stenting – European Review for Medical & Pharmacological Sciences 28 (8) (2024) 🩺

Professional Memberships

He is an active member of several professional societies, including the Turkish Society of Radiology and the European Society of Radiology, reflecting his engagement with the radiology community and ongoing professional development.

Certificates

Dr. Özdemir holds a Diploma from the Turkish Society of Interventional Radiology (2019), underscoring his specialized skills and recognition in the field.

Languages

He is fluent in English and Turkish, allowing him to collaborate effectively with international peers and contribute to global research efforts.

Hobbies and Interests

Outside of his professional life, Dr. Özdemir enjoys reading, riding motorcycles, camping, scuba diving, and traveling, which highlights his well-rounded personality and diverse interests.

Conclusion

Dr. Mustafa Özdemir’s extensive education, diverse professional experience, significant research contributions, active memberships, and certifications make him an excellent candidate for the Research for Best Researcher Award.

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Published on by Academic Awards

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Dr Cristina Papayannidis, IRCCS, Azienda Ospedaliero Universitaria S.Orsola Malpighi, Bologna, Italy, Italy

Dr. Cristina Papayannidis appears to be an outstanding candidate for the Best Researcher Award based on several key criteria:

Publication profile

scopus

Extensive Experience

Dr. Papayannidis has been deeply involved in clinical research and patient care in hematology since her early career. Her role as Dirigente Medico Ematologia at IRCCS Azienda Ospedaliero Universitaria di Bologna highlights her leadership in AML and ALL clinical trials.

High Research Output

She has authored over 130 publications and has been a principal or sub-investigator in more than 60 phase 1-3 clinical trials, showcasing her significant contributions to advancing hematology research.

Recognition and Influence

With an H-index of 34, she has made substantial impacts in her field. Her role as a speaker at over 300 national and international events, including prestigious conferences like ASH and EHA, underscores her influential presence in the hematological community.

Mentorship and Leadership

Her positions as a mentor in EHA Master Classes and member of various working groups demonstrate her commitment to guiding the next generation of researchers and shaping the future of hematology.

Professional Memberships

  1. Memberships in esteemed organizations such as SIE, EHA, and AACR, and her role on the Hematological Malignancies Committee ESMO further reflect her prominent status and active participation in the scientific community.

Dr. Papayannidis’s extensive research experience, high publication volume, significant impact on clinical practice, and active involvement in mentorship and professional societies make her a highly suitable candidate for the Best Researcher Award.

 

Research focus
The research focus of the individuals associated with these articles centers on hematological malignancies and their management. They investigate advanced treatments and strategies for diseases like acute lymphoblastic leukemia (ALL), particularly in the context of drug therapies and stem cell transplantation. Key topics include evaluating the efficacy of ponatinib versus imatinib in treating Philadelphia chromosome-positive ALL, using ponatinib to prevent relapse after transplantation, and assessing the impact of inotuzumab ozogamicin on outcomes and complications in refractory cases. Their work contributes to improving therapeutic approaches and patient outcomes in hematology. 🩺💉🔬

Publication top notes

Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)

Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission †

Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease